COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home   »   Resources   »   Publications

Publications

Read the latest publications from the PDA...

  • Welcome to your February 2025 PDA Scotland Update

    Sun 16th February 2025 The PDA

    Keeping you informed of PDA activities within Scotland. 

  • PDA launches case against the liberalisation of P medicine sales

    Thu 13th February 2025 The PDA

    The PDA has today launched a report against allowing Pharmacy (P) medicines to be available for self-selection from open displays in community pharmacies. 

  • Insight Online – December 2024

    Mon 30th December 2024 The PDA

    This month, read our response to a communication sent to pharmacists by Superdrug management and guidance for those who sat the November 2024 registration assessment and are making an appeal.  

  • Intersection Update – November 2024

    Thu 28th November 2024 The PDA

    Intersection is the PDA's newsletter bringing together news from all four PDA Equality, Diversity, and Inclusion (EDI) Networks. We encourage all PDA members to get involved in the networks that are of interest to them. 

  • Insight Online – November 2024

    Wed 27th November 2024 The PDA

    This month, read about the government's consultation that aims to shape a 10-year health plan for the NHS in England. Also, read our response to the GPhC's consultation on changes to the ‘guidance for registered pharmacies providing pharmacy services at a distance, including on the internet’. Plus, access FREE PDA resources designed to keep you safe at work.  

  • PDA BAME Network launches factsheet to mark Sickle Cell Awareness Month

    Sun 1st September 2024 The PDA

    To mark Sickle Cell Awareness Month, the PDA BAME Network has published a factsheet to help raise awareness of the disease and help employers understand that pharmacists diagnosed with sickle cell may need time off work for medical appointments and treatment.  

  • Welcome to the August 2024 PDA Education Update

    Thu 1st August 2024 The PDA

    PDA Education provides FREE training and support to PDA members. This newsletter highlights the latest activities, training opportunities, and support available. 

  • Insight Online – May 2024

    Thu 30th May 2024 The PDA

    This month, learn about how we are supporting a wider role for pharmacists and find out why we can't support DiCE's best practice guidance for online prescribing. Plus, read about some of the ways you can get involved in helping to improve the working lives of pharmacists. 

  • Insight Online – April 2024

    Mon 29th April 2024 The PDA

    This month, learn about how we are defending our members by fighting the discrimination they face and how the Pharmacy First thresholds are adding pressure on pharmacists. Plus, read about some useful resources that will support you in your career! 

  • Welcome to the April 2024 PDA Education Update

    Wed 3rd April 2024 The PDA

    PDA Education provides FREE training and support to PDA members. This newsletter highlights the latest activities, training opportunities, and support available. 

Next Page Next

Page 1 of 8

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)